Cardiac troponin T levels for risk stratification in acute myocardial ischemia

New England Journal of Medicine

Volumn 335, Issue 18, 1996, Pages 1333-1341

  Ohman, E Magnus ^a,h   Armstrong, Paul W ^b   Christenson, Robert H ^c   Granger, Christopher B ^a   Katus, Hugo A ^d   Hamm, Christian W ^e   O'Hanesian, Mary Ann ^a   Wagner, Galen S ^a   Kleiman, Neal S ^f   Harrell Jr , Frank E ^a   Califf, Robert M ^a   Topol, Eric J ^g  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Philosophy and Religious Studies   (Canada)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; CREATINE KINASE MB; DESULFATOHIRUDIN; HEPARIN; HIRUDIN DERIVATIVE; REVASE; STREPTOKINASE; TROPONIN T; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; ELECTROCARDIOGRAM; FEMALE; FIBRINOLYTIC THERAPY; HEART MUSCLE ISCHEMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SINGLE BLIND PROCEDURE; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; T WAVE;

ACUTE DISEASE; AGED; BIOLOGICAL MARKERS; CREATINE KINASE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; ISOENZYMES; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; RISK; STATISTICS, NONPARAMETRIC; TROPONIN; TROPONIN T;

EID: 0006894580     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199610313351801     Document Type: Article

References (46)

1. Califf RM, Mark DB, Harrell FE Jr, et al. Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease. J Am Coll Cardiol 1988;11:20-6.
2. Betriu A, Heras M, Cohen M, Fuster V. Unstable angina: outcome according to clinical presentation. J Am Coll Cardiol 1992;19:1659-63.
3. Braunwald E. Unstable angina: a classification. Circulation 1989;80: 410-4.
4. Calvin JE, Klein LW, VandenBerg BJ, et al. Risk stratification in unstable angina: prospective validation of the Braunwald classification. JAMA 1995;273:136-41.
5. Cohen M, Hawkins L, Greenberg S, Fuster V. Usefulness of ST-segment changes in greater than or equal to 2 leads on the emergency room electrocardiogram in either unstable angina pectoris or non-Q-wave myocardial infarction in predicting outcome. Am J Cardiol 1991;67:1368-73.
6. Rude RE, Poole WK, Muller JE, et al. Electrocardiographic and clinical criteria for recognition of acute myocardial infarction based on analysis of 3,697 patients. Am J Cardiol 1983;52:936-42.
7. Yusuf S, Pearson M, Sterry H, et al. The entry ECG in the early diagnosis and prognostic stratification of patients with suspected acute myocardial infarction. Eur Heart J 1984;5:690-6.
8. Lee TH, Rouan GW, Weisberg MC, et al. Sensitivity of routine clinical criteria for diagnosing myocardial infarction within 24 hours of hospitalization. Ann Intern Med 1987;106:181-6.
9. Karlson BW, Herlitz J, Wiklund O, Richter A, Hjalmarson A. Early prediction of acute myocardial infarction from clinical history, examination and electrocardiogram in the emergency room. Am J Cardiol 1991;68:171-5.
10. Donnelly R, Hillis WS. Cardiac troponin T. Lancet 1993;341:410-1.
11. Katus HA, Looser S, Hallermayer K, et al. Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin Chem 1992;38:386-93.
12. Hamm CW, Ravkilde J, Gerhardt W, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992;327:146-50.
13. Ravkilde J, Herder M, Gerhardt W, et al. Diagnostic performance and prognostic value of serum troponin T in suspected myocardial infarction. Scand J Clin Lab Invest 1993;53:677-85.
14. Seino Y, Tomita Y, Takano T, Hayakawa H. Early identification of cardiac events with serum troponin T in patients with unstable angina. Lancet 1993;342:1236-7.
15. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. Circulation 1994; 90:1631-7.
16. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82.
17. Hindman NB, Schocken DD, Widmann M, et al. Evaluation of a QRS scoring system for estimating myocardial infarct size. V. Specificity and method of application of the complete system. Am J Cardiol 1985;55: 1485-90.
18. Wu AHB, Valdes R Jr, Apple FS, et al. Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction. Clin Chem 1994;40:900-7.
19. Horder M, Magid E, Pitkanen E, et al. Recommended method for the determination of creatine kinase in blood modified by the inclusion of EDTA. Scand J Clin Lab Invest 1979;39:l-5.
20. Vaidya HC, Maynard Y, Dietzler DN, Ladenson JH. Direct measurement of creatine kinase-MB activity in serum after extraction with a monoclonal antibody specific to the MB isoenzyme. Clin Chem 1986,32:657-63.
21. Holmes DR Jr, Bates ER, Kleiman NS, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. J Am Coll Cardiol 1995;26:668-74.
22. Friedman JH. A variable span smoother: technical report. Palo Alto, Calif.: Department of Statistics, Stanford University, 1984.
23. S-Plus users' manual, version 3.3. Seattle: Statistical Sciences, 1995.
24. Harrell FE Jr, Lee KL, Pollock BG. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst 1988;80:1198-202.
25. Akaike H. Maximum likelihood identification of Gaussian autoregressive moving average models. Biometrika 1973;60:255-65.
26. Lee TH, Cook EF, Weisberg M, Sargent RK, Wilson C, Goldman L. Acute chest pain in the emergency room: identification and examination of low-risk patients. Arch Intern Med 1985;145:65-9.
27. Ravkilde J, Nissen H, Horder M, Thygesen K. Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction: analysis of 28 months of follow-up in 196 patients. J Am Coll Cardiol 1995;25: 574-81.
28. Katus HA, Remppis A, Neumann FJ, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 1991; 83:902-12.
29. Burlina A, Zaninotto M, Secchiero S, Rubin D, Accorsi F. Troponin T as a marker of ischemic myocardial injury. Clin Biochem 1994;27:113-21.
30. Remppis A, Scheffold T, Karrer O, et al. Assessment of reperfusion of the infarct zone after acute myocardial infarction by serial cardiac troponin T measurements in serum. Br Heart J 1994;71:242-8.
31. Zabel M, Hohnloser SH, Koster W, Prinz M, Kasper W, Just H. Analysis of creatine kinase, CK-MB, myoglobin, and troponin T time-activity curves for early assessment of coronary artery reperfusion after intravenous thrombolysis. Circulation 1993;87:1542-50.
32. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22. [Erratum, Lancet 1994;343:742.]
33. The LATE Investigators. Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet 1993;342:759-66.
34. Harper RW, Kennedy G, DeSanctis RW, Hutter AM Jr. The incidence and pattern of angina prior to acute myocardial infarction: a study of 577 cases. Am Heart J 1979;97:178-83.
35. Ohman EM, Califf RM, Topol EJ, et al. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. Circulation 1990;82:781-91.
36. Wagner I, Mair J, Fridrich L, et al. Cardiac troponin T release in acute myocardial infarction is associated with scintigraphic estimates of myocardial scar. Coron Artery Dis 1993;4:537-44.
37. van Dieijen-Visser MP, Kragten JA, Westerhuis LWJJM, Hermens WT. Quantification of troponin T release in plasma after acute myocardial infarction. Ned Tijdschr Klin Chem 1995;20:120. abstract.
38. Norregaard-Hansen K, Egstrup K, Nielsen JR, et al. Lack of indication of myocardial cell damage after myocardial ischaemia in patients with severe stable angina. Eur Heart J 1992;13:188-93.
39. Armstrong PW, Chiong MA, Parker JO. The spectrum of unstable angina: prognostic role of serum creatine kinase determination. Am J Cardiol 1982;49:1849-52.
40. Hedges JR, Young GP, Henkel GF, Gibler WB, Green TR, Swanson JR. Serial ECGs are less accurate than serial CK-MB results for emergency department diagnosis of myocardial infarction. Ann Emerg Med 1992;21: 1445-50.
41. Mair J, Artner-Dworzak E, Lechleitner P, et al. Cardiac troponin T in diagnosis of acute myocardial infarction. Clin Chem 1991;37:845-52.
42. Lindahl B, Toss H, Venge P, Wallentin L. Troponin T is a strong prognostic marker for subsequent cardiac events in patients with unstable angina. Eur Heart J 1995;16:Suppl:40. abstract.
43. Abbas SA, Green S, Wu AHB, et al. Serum cardiac troponin T measurements in unstable angina: an early, accurate marker of increased risk. J Am Coll Cardiol 1995;25(Special Issue):147A-148A. abstract.
44. Bhayana V, Gougoulias T, Cohoc S, Henderson AR. Discordance between results for serum troponin T and troponin I in renal disease. Clin Chem 1995;41:312-7.
45. Latner BP, Skale JS, Burns W. Measuring creatine kinase MB isoenzyme in a maintenance hemodialysis population: chemiluminometric immunoassay and electrophoresis compared. Clin Chem 1989;35:1965-8.
46. Antman EM, Grudzien C, Sacks DB. Evaluation of a rapid bedside assay for detection of serum cardiac troponin T. JAMA 1995;273: 1279-82.